About 40 scientists have written an open letter to the developers of the Russian vaccine demanding that original data be made available, as the paper published in the Lancet did not present full data. In that study, the developers had claimed that the vaccine had been found to be safe in phase-1 and phase-2 trials, and it had also triggered “strong” immune response in the participants.
